FindTrial
Sign In

Clinical studies of intestinal flora lead the formation and development of insulin resistance

Clinical studies of intestinal flora lead the formation and development of insulin resistance

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-COC-15006218
Enrollment
Unknown
Registered
2015-04-08
Start date
2015-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

Case series:Nil

Sponsors

Haikou municipal peoples hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: insulin, C-peptide release test shows abnormal insulin resistance and does not meet the diagnostic criteria for diabetes.

Exclusion criteria

Exclusion criteria: Diabetes, hypertension, heart disease.

Design outcomes

Primary

MeasureTime frame
intestinal flora;—

Countries

China

Contacts

Public ContactYang Xuejun
my006@yahoo.com+86 0898 66151168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026